Bone marrow-derived mesenchymal stem cells for the treatment of heart failure (Q38214941)

31 August 2017

title

Bone marrow-derived mesenchymal stem cells for the treatment of heart failure (English)

1 reference

31 August 2017

0 references

mesenchymal stem cell

1 reference

Takuya Narita

1 reference

31 August 2017

Ken Suzuki

series ordinal

1 reference

31 August 2017

publication date

1 January 2015

1 reference

31 August 2017

published in

Heart Failure Reviews

1 reference

31 August 2017

1 reference

31 August 2017

1 reference

31 August 2017

page(s)

53-68

1 reference

The inflammatory response in myocardial infarction

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Vascular endothelial growth factor-induced neovascularization rescues cardiac function but not adverse remodeling at advanced ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Left ventricular remodeling after myocardial infarction: pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Immunomodulatory properties of mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Potential risks of bone marrow cell transplantation into infarcted hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

What is the oncologic risk of stem cell treatment for heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Cell sheet engineering: a unique nanotechnology for scaffold-free tissue reconstruction with clinical applications in regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Cell sheet engineering: recreating tissues without biodegradable scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Cardiomyocytes can be generated from marrow stromal cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Immunological aspects of allogeneic mesenchymal stem cell therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Combination stem cell therapy for the treatment of medically refractory coronary ischemia: a Phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Concise review: hitting the right spot with mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

The use of scaffold-free cell sheet technique to refine mesenchymal stromal cell-based therapy for heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

The use of cell-sheet technique eliminates arrhythmogenicity of skeletal myoblast-based therapy to the heart with enhanced therapeutic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Trypsin-induced proteome alteration during cell subculture in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Cell delivery routes for stem cell therapy to the heart: current and future approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mesenchymal stromal cells for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

In vivo myocardial distribution of multipotent progenitor cells following intracoronary delivery in a swine model of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Clinical impact of combined transplantation of autologous skeletal myoblasts and bone marrow mononuclear cells in patients with severely deteriorated ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mesenchymal stem cells can be differentiated into endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Post-ischemic myocardial fibrosis occurs independent of hemodynamic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Reverse remodeling is associated with changes in extracellular matrix proteases and tissue inhibitors after mesenchymal stem cell (MSC) treatment of pressure overload hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Apoptosis in myocardial ischaemia and infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Bone marrow stromal cells mediate protection through stimulation of PI3-K/Akt and MAPK signaling in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Optimising human mesenchymal stem cell numbers for clinical application: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mycoplasma contamination of cell cultures: Incidence, sources, effects, detection, elimination, prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mesenchymal stromal cells: a key player in 'innate tolerance'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Bone marrow-derived stem cell transplantation for the treatment of insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Comparison of different adult stem cell types for treatment of myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Myocardial injection with GSK-3β-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Epicardial deposition of endothelial progenitor and mesenchymal stem cells in a coated muscle patch after myocardial infarction in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mesenchymal stem cells improve outcomes of cardiopulmonary resuscitation in myocardial infarcted rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Transcriptional profiling of young and old mesenchymal stem cells in response to oxygen deprivation and reparability of the infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Microencapsulation to reduce mechanical loss of microspheres: implications in myocardial cell therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Impact of escaped bone marrow mesenchymal stromal cells on extracardiac organs after intramyocardial implantation in a rat myocardial infarction model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

The apelin-APJ pathway exists in cardiomyogenic cells derived from mesenchymal stem cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

A comparison of the efficacy of transplantation of bone marrow-derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Improvement in hemodynamic performance, exercise capacity, inflammatory profile, and left ventricular reverse remodeling after intracoronary delivery of mesenchymal stem cells in an experimental model of pressure overload hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Preventing cardiac remodeling: the combination of cell-based therapy and cardiac support therapy preserves left ventricular function in rodent model of myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Myocardium-targeted transplantation of mesenchymal stem cells by diagnostic ultrasound-mediated microbubble destruction improves cardiac function in myocardial infarction of New Zealand rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

CT for evaluation of myocardial cell therapy in heart failure: a comparison with CMR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Stem cells for myocardial repair with use of a transarterial catheter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Early improvement in cardiac tissue perfusion due to mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Effect of transplantation with autologous bone marrow stem cells on acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Cardiopoietic Stem Cell Therapy in Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Interleukin-10 From Transplanted Bone Marrow Mononuclear Cells Contributes to Cardiac Protection After Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Cell transplantation: Differential effects of myoblasts and mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9435-X

Increasing post-myocardial infarction heart failure incidence in elderly patients a call for action

21 January 2018

1 reference

12 December 2020

Aged human cells rejuvenated by cytokine enhancement of biomaterials for surgical ventricular restoration

1 reference

12 December 2020

A critical challenge: dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction

1 reference

12 December 2020

Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use

1 reference

12 December 2020

Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats

1 reference

12 December 2020

Transplantation of angiogenin-overexpressing mesenchymal stem cells synergistically augments cardiac function in a porcine model of chronic ischemia

1 reference

12 December 2020

Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor

1 reference

12 December 2020

Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction

1 reference

12 December 2020

Marrow-derived MSCs and atorvastatin improve cardiac function in rat model of AMI

1 reference

12 December 2020

The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells

1 reference

12 December 2020

Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction

1 reference

12 December 2020

Transforming growth factor-α enhances stem cell-mediated postischemic myocardial protection

1 reference

12 December 2020

Stem cell therapy enhances electrical viability in myocardial infarction

1 reference

12 December 2020

Comparison of Human Adipose-Derived Stem cells and Bone Marrow-Derived Stem cells in a Myocardial Infarction Model

1 reference

12 December 2020

Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells

1 reference

12 December 2020

Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart

1 reference

12 December 2020

Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium

1 reference

12 December 2020

Fibroblast precursors in normal and irradiated mouse hematopoietic organs

1 reference

12 December 2020

Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction

1 reference

12 December 2020

Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy

1 reference

12 December 2020

Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart.

1 reference

12 December 2020

Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction

1 reference

12 December 2020

Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance

1 reference

12 December 2020

Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion

1 reference

12 December 2020

Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues

1 reference

12 December 2020

Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts

1 reference

12 December 2020

Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction

1 reference

12 December 2020

Effects of bone marrow mesenchymal stem cells in a rat model of myocardial infarction

1 reference

12 December 2020

Mesenchymal Stem Cells Provide Better Results Than Hematopoietic Precursors for the Treatment of Myocardial Infarction

1 reference

12 December 2020

Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model

1 reference

12 December 2020

10.1007/S10741-014-9435-X

Identifiers

DOI

1 reference

31 August 2017

1 reference